Leap Therapeutics (LPTX)
(Real Time Quote from BATS)
$0.31 USD
-0.02 (-4.94%)
Updated Aug 7, 2025 12:50 PM ET
3-Hold of 5 3
C Value C Growth B Momentum B VGM
Fundamental Charts
About Market Cap
As of the previous market close, Leap Therapeutics, Inc. has a market cap of $13.51M, which represents its share price of $0.33 multiplied by its outstanding shares number of 41.44M. As a small-cap company, LPTX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
LPTX 0.31 -0.02(-4.94%)
Will LPTX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for LPTX based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for LPTX
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's After-Market Session
Leap Therapeutics (LPTX) Shows Promising Results in Phase 2 Study | LPTX Stock News
Leap Therapeutics (LPTX) Announces Significant Workforce Reduction | LPTX Stock News
Leap Therapeutics to cut workforce by 75%, explore strategic alternatives